XML 39 R28.htm IDEA: XBRL DOCUMENT v3.25.2
Stockholders’ Equity (Tables)
 12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Schedule of company recognized stock compensation expense
               
    Years Ended
December 31,		  
    2024     2023  
Cost of services   $ -     $ (442 )
Research and development     48,820       (10,647 )
General and administrative     549,216       333,863  
Sales and marketing     4,397       (86,800 )
    $ 602,433     $ 235,974  
Schedule of stock option activity
                               
    Number of
Options		     Weighted-
Average
Exercise
Price		     Weighted-
Average
Remaining
Contractual Life
(in years)		     Aggregate
Intrinsic
Value		  
Outstanding at December 31, 2022     10,761     $ 934.50       7.9     $ -  
Granted     -     $ -                  
Exercised     -     $ -                  
Forfeited     (420 )   $ 299.80                  
Expired     (717 )   $ 1,012.10                  
Outstanding at December 31, 2023     9,624     $ 1,064.84       6.8     $ -  
Granted     -     $ -                  
Exercised     -     $ -                  
Forfeited     (892 )   $ 314.61                  
Expired     (8,594 )   $ 1,158.04                  
Outstanding at December 31, 2024     138     $ 110.26       7.5     $ -  
Vested and expected to vest     138     $ 110.26       7.5     $ -  
Exercisable at December 31, 2024     138     $ 110.26       7.5     $ -  
Schedule of restricted stock unit activity
               
    Number of
units		     Weighted-
Average
Grant Date
Fair Value		  
Unvested at December 31, 2022     4,291     $ 173.30  
Granted      10,050     $ 1.06  
Vested     (3,465 )   $ 181.63  
Forfeited     (2,550 )   $ 19.70  
Unvested at December 31, 2023     8,326     $ 20.55  
Granted     250,783     $ 2.83  
Vested     (63,721 )   $ 7.12  
Forfeited     (5,151 )   $ 27.28  
Unvested at December 31, 2024     190,237     $ 1.74  
Schedule of stock purchase warrants
                               
      Exercise           Outstanding at
December 31,		  
Issuance     Price     Expiration     2024     2023  
February 2015     $ 660,000.00     February 2025       3       3  
October 2019     $ 400.00     October 2024       -       1,770  
October 2019     $ 520.00     October 2024       -       1,175  
November 2020     $ 504.40     May 2026       1,211       1,211  
February 2021     $ 780.00     August 2026       2,084       2,084  
May 2023     $ 7.79     (1)     889,274       889,274  
October 2023     $ 3.36     April 2029       200,000       200,000  
                      1,092,572       1,095,517  

 

The warrants listed above were issued in connection with various equity, debt, or development contract agreements.

 

(1) Warrants will be exercisable beginning on the date of stockholder approval of the exercisability of the warrants under Nasdaq rules. Once exercisable, the warrants will expire on the five-year anniversary of the date of such stockholder approval.